Recent studies conducted by scientists discover new effects of medications that slow the progression of prostate cancer in the late...
Archive for category: Press Releases
Dr. David Samadi Explains How Latest Prostate Cancer Research Could Lead to More Personalized Treatment for Improved Outcomes
Dr. David Samadi, chairman of Urology at Lenox Hill Hospital comments on studies finding that prostate cancer research can lead to personalized treatment of...
Dr. David Samadi Discusses Using Urine Samples To Predict Prostate Cancer
Dr. David Samadi, Chairman of Urology at Lenox Hill Hospital, gives his expert opinion on the use of metabolic profiling on using urine samples for...
Dr. David Samadi Explains The Role of Mediterranean Diet In Lowering The Risk Of Aggressive Prostate Cancer
Dr. David Samadi, Chairman of Urology at Lenox Hill Hospital, discusses latest research on the link between following a Mediterranean dietary pattern...
Fluctuations in Testosterone Levels May Predict Prostate Cancer Risk
Dr. David Samadi, Chairman of Urology at Lenox Hill Hospital, gives his expert opinion on a new study suggesting unstable testosterone or a significant...
PSA Screening Decreases Risk Of Dying From Prostate Cancer, Says New Studies
Dr David Samadi shares his expert commentary on a recent study finding PSA screening for prostate cancer reduces deaths from prostate cancer...
Androgen Deprivation Therapy Associated With Increased Risk Of Cardiovascular Disease
Dr David Samadi provides his opinion on a prospective cohort study which found an association between men using androgen deprivation therapy for...
Prostate Cancer Patients Improve Bone Health with Osteoporosis Drugs by Dr David Samadi
New study finds men with prostate cancer who are receiving androgen deprivation therapy have improved bone mineral density using osteoporosis medications.
Black Men’s Prostate Cancer Survival Partially Dependent On Racial Differences In Definitive Therapy By Dr David Samadi
Dr David Samadi comments on a study finding significant differences in radiation and surgical treatment for prostate cancer among white and black men...
Safety Concerns Over Active Surveillance for Intermediate-risk Prostate Cancer
Dr. David Samadi provides his expert opinion on a recent study regarding safety of active surveillance for men with intermediate-risk prostate cancer...